What Is BPC-157?

If you've spent any time reading about peptide research, you've almost certainly come across BPC-157. It has one of the longest track records in modern peptide science — decades of animal studies, a well-characterized mechanism, and a growing body of literature that spans gut health, tendon repair, and even neurological function. But for someone encountering it for the first time, the name alone raises an obvious question: what exactly is it, and where does it come from?

What Is BPC-157?

BPC-157 stands for Body Protective Compound 157. It is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protein found naturally in human gastric juice. The parent protein, BPC (body protective compound), was first isolated from the stomach lining, where it appears to play a role in protecting the gastric mucosa from damage and supporting tissue repair. Researchers isolated and sequenced a specific fragment of this protein and designated it BPC-157 based on its position in their screening process.

The amino acid sequence of BPC-157 is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. That precise arrangement is what gives the peptide its biological activity. Unlike many naturally occurring peptides, BPC-157 shows exceptional stability in acidic environments — it is not broken down by stomach acid the way most peptide sequences would be — which partly explains the research interest in administering it orally in animal models.

Where Does It Come From?

The research program that produced BPC-157 originated in Croatia, primarily from the lab of Predrag Sikiric at the University of Zagreb. Sikiric and his colleagues have been the most prolific publishers on this compound, producing hundreds of studies over three decades. The original hypothesis was straightforward: if the stomach naturally produces a protein that protects tissue, perhaps isolating and concentrating a bioactive fragment of that protein could be useful in research models.

It's worth noting that BPC-157 is entirely synthetic — it is produced in a laboratory, not extracted from biological sources. The "derived from gastric juice" origin refers to the sequence template used to design the peptide, not its manufacturing process.

What Does the Research Show?

The animal model literature on BPC-157 is unusually broad. Three areas dominate the published research: gastrointestinal healing, tendon and muscle repair, and systemic tissue protection.

On the gut healing side, BPC-157 has been studied in rodent models of inflammatory bowel disease, gastric ulcers, and intestinal fistulas. A 2018 review by Sikiric and colleagues in Current Pharmaceutical Design summarized the evidence suggesting that BPC-157 may upregulate growth hormone receptor expression in the gut and modulate nitric oxide pathways, both of which are involved in mucosal repair. In various animal models, BPC-157 administration appeared to accelerate the healing of gastric and intestinal lesions and reduce markers of inflammation.

The tendon healing research is equally compelling. A 2011 study by Chang and colleagues published in the Journal of Applied Physiology examined BPC-157's effects on tendon explant cultures and animal tendon injury models. The researchers found that BPC-157 increased the in-vitro outgrowth of tendon fibroblasts and appeared to accelerate tendon-to-bone healing in the animal model. The proposed mechanism involved upregulation of the tendon growth factor VEGF (vascular endothelial growth factor), which is critical for new blood vessel formation during tissue repair.

A 2019 review by Gwyer and colleagues in Current Pharmaceutical Design took a broader look at BPC-157's tissue repair mechanisms, noting its apparent effects on angiogenesis, collagen production, and the nitric oxide system. The authors described BPC-157 as showing "pleiotropic" effects — meaning it seems to work through multiple pathways simultaneously rather than having a single narrow mechanism.

How Is BPC-157 Used in Research Settings?

In laboratory research, BPC-157 is typically supplied as a lyophilized (freeze-dried) powder and requires reconstitution before use. Researchers generally reconstitute it using bacteriostatic water, which allows the resulting solution to be stored for an extended period without microbial contamination. Once reconstituted, the solution should be kept refrigerated and protected from light.

Dosing in animal studies has varied widely depending on the model and administration route. Subcutaneous injection and intraperitoneal injection are the most common methods used in rodent studies, though some oral and intragastric administration studies also exist. Researchers interested in replicating or extending prior work will typically reference the half-life data and study-specific protocols when designing their experimental parameters. You can also use the peptide calculator to assist with solution concentration calculations.

Storage of lyophilized BPC-157 typically calls for freezer conditions (around -20°C) to preserve potency over the long term, while reconstituted solutions are generally refrigerated at 2–8°C and used within a defined window.

Key Things to Know Before Diving Into the Literature

A few important context points for anyone approaching the BPC-157 research base for the first time:

• The evidence base is almost entirely preclinical. The vast majority of BPC-157 studies have been conducted in rodents. Human clinical trials are limited, and no regulatory agency has approved BPC-157 as a therapeutic agent.
• Many studies come from a single research group. The Sikiric lab at Zagreb has been responsible for a large proportion of the published literature, which means independent replication — while it does exist — is less comprehensive than for some other research peptides.
• The mechanisms proposed are plausible but not fully characterized. Nitric oxide modulation, VEGF upregulation, and growth hormone receptor interaction are all reasonable pathways, but the precise mechanism by which BPC-157 exerts its effects is still a subject of ongoing investigation.
• Stability is a genuine research advantage. Unlike many peptides that degrade rapidly in physiological conditions, BPC-157's acid stability and reported resistance to enzymatic breakdown make it an interesting model compound for studying peptide bioavailability.

For researchers looking to go deeper, the Alpha Tides Research Library contains detailed compound profiles, study summaries, and protocol references. BPC-157 remains one of the most-studied peptides in the preclinical literature, and the volume of available material makes it a productive area for laboratory investigation.